Sumant Ramachandra is the founder of ImmPACT Bio. ImmPACT Bio has raised $129M in total funding. Latest round: Series B. Backed by venBio Partners.
Sumant Ramachandra is the Co-founder, President, and Chief Executive Officer (CEO) of ImmPACT Bio, a biotechnology company focused on developing cell therapies for cancer treatment. He joined ImmPACT Bio's board of directors and became CEO in January 2022, bringing experience from previous roles at Baxter and Pfizer.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide